The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IWWM-11 2022 | The importance of monitoring COVID-19 in patients with Waldenström’s macroglobulinemia
Lee Greenberger, PhD, Leukemia & Lymphoma Society, New York, NY, discusses the importance of monitoring COVID-19 in patients with Waldenström’s macroglobulinemia (WM), and highlights various methods that may be used. Dr Greenberger also shares some insights into a survey which investigated breakthrough infections in patients after vaccination or administration of Evusheld, and highlights the significance of monitoring breakthrough infections in patients with hematological malignancies. This interview took place at the 11th International Workshop on Waldenström’s Macroglobulinemia (IWWM-11), held in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
